Search

Bioprospect’s new board

Retiring Bioprospect chairman Winton Willesee has been replaced by Silvi Elkhouri as director and Peter May as non-executive chairman of the company.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Medibio (MEB)

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 29/06/18

1 year TSR5 year TSR
37thiCollege275%5%
148thSterling Plantations88%-24%
239thFamily Zone Cyber Safety44%0%
389thKatana Capital11%5%
773rdMedibio-63%6%
722 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

18/06/18
$0 Issued
18/06/18
$0 Issued
18/06/18
$0 Issued
Total value as at the date of the transaction
Source: Morningstar

Revenue

110th↑Medibio$3.1m
121st↓Katana Capital$2.4m
122nd↓Sterling Plantations$2.3m
124th↑Family Zone Cyber Safety$2.3m
125th↓iCollege$2.0m
239 listed industrial companies ranked by revenue.
Source: Morningstar

Remuneration from Medibio

842ndFrank Prendergast$119k
536thChris Indermaur$50k
Ranked by total remuneration from all listed WA companies

BNiQ Disclaimer